Showing results (1471-1480 of 3,085) with videos related to

Sort By:
Pageof 309
Drug Safety|November 2, 2024
Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative StudyEyob Alemayehu Gebreyohannes, Christopher Thornton, Myra Thiessen, et al.
Drug Safety|December 4, 2024
Prenatal Exposure to Proton Pump Inhibitors and Risk of Serious Infections in Offspring During the First Year of Life: A Nationwide Cohort StudyMylène Tisseyre, Mathis Collier, Nathanaël Beeker, et al.
Drug Safety|December 5, 2024
Early Detection of Hearing Impairment Signals Post-mRNA COVID-19 Vaccination: A Disproportionality Analysis Study on French Pharmacovigilance DatabaseDalil Boulefaa, Haleh Bagheri, Francesco Salvo, et al.
Drug Safety|November 28, 2024
Fracture-Related Safety Reporting of JAK Inhibitors: An Analysis from the WHO Global VigiBaseAdrian Martinez de la Torre, Andreas Bech Clausen, Andrea M Burden, et al.
Drug Safety|November 21, 2024
Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case StudyMathias Møllebæk, Helga Gardarsdottir, Alexia-Georgia Bikou, et al.
Drug Safety|March 20, 2025
Mitigation and Management of Common Toxicities Associated with the Administration of CAR-T Therapies in Oncology PatientsJonathan Renninger, Lisa Kurz, Heather Stein
Drug Safety|September 12, 2024
Qualitative Interviews with Stakeholders in Herbal Pharmacovigilance and Recommendations for Best Practices to be Applied WorldwideCorine Ekhart, Sjoerd H P Wiarda, Sonja van de Koppel, et al.
Drug Safety|September 3, 2024
Cardiovascular Safety of Romosozumab Compared to Commonly Used Anti-osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-analysis of Randomized Controlled TrialsShih-Hao Cheng, William Chu, Wen-Hsiang Chou, et al.
Drug Safety|July 16, 2024
A Systematic Overview of Contraindications and Special Warnings for Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Establishing a Framework to Create a "Safety Checklist"Lykke Skaarup, Elvina Ingrid, Alexandre Sepriano, et al.
Drug Safety|July 31, 2024
Description and Validation of a Novel AI Tool, LabelComp, for the Identification of Adverse Event Changes in FDA LabelingGeorge A Neyarapally, Leihong Wu, Joshua Xu, et al.
Pageof 309